Goodwin, Latham Steer Life Sciences IPOs Totaling $244.5M

Law360 (September 13, 2019, 3:29 PM EDT) -- Two life sciences companies — clinical-stage, rare diseases- and cancer-focused SpringWorks and migraine-focused Satsuma — raised a combined $244.5 million in a pair of initial public offerings Friday steered by Goodwin Procter and Latham, respectively.

Leading the way Friday was Goodwin Procter LLP-led SpringWorks Therapeutics Inc.'s 9 million share offering that raised $162 million after the biotechnology company priced at $18 per share. SpringWorks said in a filing with the U.S. Securities and Exchange Commission this week that it planned to offer its shares between $16 and $18.

SpringWorks began trading Friday on the Nasdaq Global Select Market under the symbol...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS